BuzzFeed: Could Pot Help Solve The Opioid Crisis?

Published on BuzzFeed on November 15, 2018 by Dan Vergano Scott Jordan never thought weed would help him kick the painkillers he took for a bad back. “I smoked pot in high school,” he told BuzzFeed News. “I didn’t really believe medical marijuana was going to help me.” But the 58-year-old New Yorker, a longtime Read More

Columbia Care Leads US Cannabis Industry Towards Global Expansion By Becoming First American Company Licensed in European Union

Launches EU and global expansion strategy with fully integrated license issued by federal government of Malta NEW YORK – Nov. 15, 2018 – Columbia Care Inc., the leading medical cannabis company in the United States (U.S.), announced today that it received notification that its application for licensure in Malta has been approved by Malta Enterprise, Read More

Columbia Care and The Center for Discovery to Collaborate on Study Examining the Use of Cannabis-Derived Medicines in Treating Epilepsy

Research to be led by neurologist Orrin Devinsky, M.D., director of NYU Langone’s Comprehensive Epilepsy Center and world leader in the study of epilepsy, and Dr. Terry Hamlin, associate executive director of The Center for Discovery, renowned for complex care Study will investigate the optimal dose of Columbia Care’s ClaraCeed™ and ClaraCeed Ultra™ cannabis-derived tablets Read More

Columbia Care Secures Good Manufacturing Practice (GMP) Certification for Medical Cannabis Manufacturing Facility in Florida

Columbia Care Florida achieves GMP certification, reinforcing its commitment to quality and safety in medical cannabis manufacturing Manufacturing facility reports record tolerance specifications of less than 1% active pharmaceutical ingredient (API) variability across initial production batches ARCADIA, FL – Nov. 6, 2018 – Columbia Care Inc., the nation’s leading medical cannabis company, today announced that Read More

Columbia University Receives National Institute on Drug Abuse (NIDA) Research Grant to Study Impact of Medical Cannabis on Opioid Use in Collaboration with Columbia Care

Grant research will build upon Columbia Care’s pilot data demonstrating that 62% of neuropathy patients decreased or stopped opioid use while taking Columbia Care’s dose-metered cannabinoid medicines NEW YORK, Oct. 31, 2018 – The Columbia University Department of Psychiatry and Columbia Care Inc., the nation’s leading medical cannabis company, today announced that researchers from Columbia Read More

Columbia Care Selected by the Virginia Board of Pharmacy as One of Five Licensees to Produce and Dispense Cannabinoid-Based Medicines in Virginia

After highly competitive selection and vetting process, Columbia Care to produce CBD and THC-A oils in Health Service Area V and serve throughout the Commonwealth Full approval would make Virginia the 13th highly regulated state where Columbia Care is licensed to operate NEW YORK, NY Oct. 25, 2018 – Columbia Care Inc. (“Columbia Care”), the Read More

Cannabis Dispensary: Hidden Security

Published on Cheddar on October 11, 2018 by Brian Maclver We’ve all been there: After checking in at the counter and flashing our IDs, we take a seat and wait. Cameras are angled to cover all corners of the room, watching our every movement. A clerk calls our name, and we move into the back Read More

Cheddar: Expansion of Medical Marijuana Legalization

Published on Cheddar on October 22, 2018   Columbia Care is the largest multi-state medical canabis operator in the United States. With a total of 33 licenses in 13 states, the company is looking to make an impact in the global cannabis industry by partnering with Canaccord Genuity Growth. Nicholas Vita, CEO and co-founder of Read More

On the Move: The Ever Increasing Domestic Footprint of Columbia Care

Published on Cannabis Business Executive on October 11, 2018 by Rob Meagher   Ten days ago, the Virginia Board of Pharmacy Granted Five Pharmaceutical Processor Conditional Permits. The state originally indicated that they had a preference to award in-state operators but, noticeably, included two multi-state cannabis licensees in the permit mix. Columbia Care (CC), which Read More

Columbia Care CEO on Canada cannabis legalization

Published on CNBC on October 16, 2018   Nicholas Vita, Columbia Care CEO, discusses how Canada’s legalization of recreational marijuana on Wednesday will affect the medicinal use market and how it may influence U.S.-based regulations. Watch video here